Jefferies Financial Group Inc (JEF) Stock Price, Quote & News

Company Profile

Jefferies Financial Group Inc. operates as an investment banking and capital markets firm in the Americas, Europe, the Middle East, and the Asia-Pacific. It operates in two segments, Investment Banking and Capital Markets, and Asset Management. The company provides investment banking and advisory services for mergers or acquisitions, debt financing, restructurings, and private capital advisory transactions; underwriting and placement services related to corporate debt, municipal debt, mortgage-b...

Industry: Capital Markets

Sector: Financial Services

Phone: 212 284 2300

Website: www.jefferies.com

Address:

520 Madison Avenue, 10th Floor, New York, United States

CapitalMonk May. 12 at 5:46 PM

$JEF Price: $52.28 (-0.28%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±3.71% RSI: 70.8 | Momentum: Moderate Volume: -58.1% vs avg Volatility: 1.98% Support: $44.96 | Resistance: $53.19 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25

0 · Reply

RunnerSignals May. 11 at 8:22 PM

Upgrades Today in the Buzz $CC.X $CRNX $JEF $PR $SNAP traders rotated toward selective upgrade names while weaker momentum continued to lag the broader https://stocksrunner.com/news/2026-05-11-top-stock-upgrades-today-in-the-buzz

0 · Reply

dawnfl May. 6 at 10:47 PM

$JEF

0 · Reply

actio May. 2 at 12:01 AM

$JEF Not impossible that tomorrow we will hear additional shares have been bought.

0 · Reply

Ro_Patel Apr. 30 at 1:57 AM

US CBP: Has received more than 75,000 refund requests as of April 26 since the CAPE portal went live on April 20. More than 47,000 claims covering about 11M tariff payments were properly filed About 15% of tariff refund claims filed by US businesses have been rejected since the launch of a govt reimbursement portal CBP court filings show around 330,000 importers paid an estimated $166B in duties, of which ~$127B is considered refund-eligible. However, under US trade law, only the importer of record can file a claim. Consumers have no standing at the portal. Businesses may only seek refunds for tariffs imposed under the International Emergency Economic Powers Act, which the Supreme Court struck down in February A secondary market for tariff refund claims has quietly emerged Hedge funds have been buying refund rights from importers at a discount in exchange for upfront cash. Claims that traded at 20 cents on the dollar before the Feb Supreme Court ruling are now changing hands at up to 60 cents on the dollar as legal visibility has improved $JEF & Oppenheimer have been active as brokers, matching hedge funds w/ importers $AAPL & $AMZN not seeking reimbursements currently, $FDX & $COST will be. President Trump was direct when asked about it: “If they don’t do that, I’ll remember them"

0 · Reply

OnlyFibs Apr. 28 at 1:41 AM

$JEF — investment banking play bouncing off $35.53 lows, now at $47.89 inside a rising wedge targeting $50.42. Q1 earnings missed EPS by 27.5% and missed revenue — market already priced it in, stock rallied. Goldman Sachs PT $54. Consensus avg PT $54.26. EPS growth forecast +29% next year, revenue +12.6%. Chart shows the blue arrow breakout thesis — needs $50.42 cleared. 🐂 Break $50.42 = $52 → $54 Goldman PT, then $62 consensus 🐻 Lose $45 = $42.25 BMO floor, then $38.60 ⚠️ SEC investigation from Dec 2025 still unresolved — class action notices active 🟢 Chart V-reversal from $35 lows on heavy volume — institutional accumulation signal 🟢 Goldman raised PT to $54 April 14 — fresh vote of confidence post-miss 🟢 IB activity picking up — M&A and deal flow rebounding in 2026 🚩 SEC probe + securities fraud class action notices from Dec 2025 — legal overhang unresolved 🚩 Oppenheimer had $97 PT in Dec — now consensus at $54, big step down in confidence#JEF #Jefferies

0 · Reply

Ro_Patel Apr. 27 at 3:16 PM

Bill Ackman's Pershing Square IPO expected to raise $5B - $PSUS The IPO of shares in Pershing Square USA Ltd., which includes complimentary shares of Pershing Square Inc., is about 85% covered by institutional investors The $5B total includes the $2.8B private placement commitments alreday secured & disclosed in filings The deal is expected to stop taking orders at 4 p.m. New York time on Monday & to price on Tuesday as scheduled Pershing Square USA will charge a 2% management fee without performance fees, while voting rights at Pershing Square are controlled by Ackman & the core management team. The IPO was targeting as much as $10B Global coordinators & lead bookrunners: $C $UBS $BAC $JEF 2026 YTD (as of 21 Apr): -2.1% FY25: +20.9% FY24: +10.2% FY23: +26.7% FY22: -8.8% FY21: +26.9%

0 · Reply

RunnerSignals Apr. 24 at 8:46 PM

big upside on paper doesnt mean it trades $ROKU $SSRM $JEF $CLX $AR follow price not targets

2 · Reply

unassuming Apr. 24 at 7:34 PM

$HIMS soon we will get $GS and $JEF PTs they will drive us into new ATH with ER soon

0 · Reply

ChristinaC Apr. 24 at 5:30 PM

$JEF is that it, the catalyst for todays reversal? The fundamentals arent at all impressive. Inconsistent and unimpressive earnings results in past several quarters

0 · Reply

Jefferies Financial files automatic mixed securities shelf

May 6, 2026, 3:00 PM EDT - 7 days ago

Jefferies Releases "Shifting Sands: Israel's Role as a Financial Capital in an Evolving Middle East,” a Comprehensive Report Highlighting Israel's Capital Market Resilience and Tech Ecosystem Strength Amid Regional Transformation

Apr 23, 2026, 5:44 PM EDT - 20 days ago

Jefferies Financial Group Inc. Announces Pricing of $1,100,000,000 5.125% Senior Notes Due 2031

2026-04-21T17:44:54.000Z - 22 days ago

‘IBM Is Well-Positioned for an Earnings Beat,’ Says Jefferies

IBM

2026-04-20T13:00:30.000Z - 23 days ago

IBM Stock Forecast Trimmed to $320 at Jefferies as Analyst Bets on “Software Re-acceleration”

IBM

2026-04-14T11:54:20.000Z - 4 weeks ago

Jefferies Financial price target raised to $54 from $47 at Goldman Sachs

Mar 26, 2026, 8:16 AM EDT - 6 weeks ago

Jefferies Stock Falls. Private Credit Problems Hit Earnings.

2026-03-26T12:12:53.000Z - 6 weeks ago

Jefferies Financial price target lowered to $44 from $49 at Morgan Stanley

2026-03-26T11:12:51.000Z - 6 weeks ago

Jefferies Financial price target lowered to $47 from $54 at Goldman Sachs

2026-03-26T02:30:00.000Z - 6 weeks ago

JEF Earnings: Jefferies Financial Group Posts Record Revenue amid Takeover Speculation

SMFG

Mar 25, 2026, 4:20 PM EDT - 7 weeks ago

Jefferies profit rises on dealmaking strength, takes hit on First Brands, MFS

Mar 25, 2026, 4:15 PM EDT - 7 weeks ago

Jefferies Announces First Quarter 2026 Financial Results

2026-03-25T17:20:15.000Z - 7 weeks ago

Jefferies Financial Group options imply 5.0% move in share price post-earnings

2026-03-25T12:05:16.000Z - 7 weeks ago

Options Volatility and Implied Earnings Moves Today, March 25, 2026

BYND BZUN CHWY CTAS KC PAYX PDD

Mar 24, 2026, 5:57 PM EDT - 7 weeks ago

It's the ‘Silence of the Lambs': Expert SOUNDS ALARM on private credit

APO ARES KKR

Mar 24, 2026, 5:53 PM EDT - 7 weeks ago

This is the start of a big crisis for private credit, says Verdad's Rasmussen

APO ARES KKR SF

2026-03-24T16:03:04.000Z - 7 weeks ago

Jefferies Stock (JEF) Gains as SMFG Explores Takeover Ahead of Earnings

SMFG

Mar 24, 2026, 10:23 AM EDT - 7 weeks ago

Jefferies Jumps on Report of Potential SMFG Takeover

SMFG

Mar 24, 2026, 10:20 AM EDT - 7 weeks ago

Jefferies stock jumps on SMFG takeover report

SMFG

Mar 24, 2026, 8:12 AM EDT - 7 weeks ago

Jefferies Bounces Premarket on Report of Potential Takeover Bid

SMFG

Mar 24, 2026, 8:04 AM EDT - 7 weeks ago

Japan's second-largest bank is considering a takeover of Jefferies

SMFG

Mar 24, 2026, 6:51 AM EDT - 7 weeks ago

Jefferies Stock Jumps. Japan's SMFG Is Planning a Possible Takeover, Report Says.

SMFG

Mar 24, 2026, 3:50 AM EDT - 7 weeks ago

Jefferies shares surge on report of Japan's SMFG preparing for potential buyout

SMFG

Mar 22, 2026, 2:00 PM EDT - 7 weeks ago

Gamestop, Carnival, Chewy, Jefferies, and More to Watch This Week

CCL CHWY GME

Mar 16, 2026, 10:00 PM EDT - 2 months ago

The Blowup That Exposed How America's Banks Are Entangled in Private Credit

WAL

Mar 11, 2026, 4:15 PM EDT - 2 months ago

Jefferies to Release its First Quarter Financial Results on March 25, 2026

Mar 10, 2026, 9:00 AM EDT - 2 months ago

Jefferies Financial Group, Inc. Investigated by the Portnoy Law Firm

Mar 9, 2026, 6:45 AM EDT - 2 months ago

Jefferies Discloses Facts About Western Alliance and Western Alliance's Loan Solely Against First Brands Receivables

Mar 6, 2026, 8:26 AM EST - 2 months ago

Jefferies Comments on Western Alliance Bank Lawsuit

Feb 27, 2026, 6:30 PM EST - 2 months ago

Private-credit ‘cockroaches' and the AI ‘scare trade' hammered stocks in February. Here's what else has investors shaken up.

APO ARES KKR OWL

Feb 27, 2026, 6:04 PM EST - 2 months ago

BMO's Brennan Hawkin talks private credit fears spooking the markets

APO ARES BX KKR OWL TPG

Feb 27, 2026, 3:34 PM EST - 2 months ago

Private credit concerns are not overblown, says Verdad's Dan Rasmussen

APO ARES OWL SF

Feb 26, 2026, 12:23 PM EST - 2 months ago

Jefferies holds $135 million exposure to collapsed UK lender MFS, Bloomberg News reports

Feb 25, 2026, 5:08 PM EST - 2 months ago

Jefferies sued by investors over losses tied to First Brands collapse

Feb 23, 2026, 11:58 AM EST - 2 months ago

Jefferies Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses

Feb 19, 2026, 8:00 AM EST - 2 months ago

M Science Launches Maddie, an AI-Powered Investment Research Copilot for the Modern Investor

Jan 13, 2026, 5:29 PM EST - 4 months ago

Jefferies Financial Group Inc. Announces Pricing of $1,500,000,000 5.500% Senior Notes Due 2036

Jan 7, 2026, 4:21 PM EST - 4 months ago

Jefferies profit rises on dealmaking rebound, strong underwriting

Jan 7, 2026, 4:15 PM EST - 4 months ago

Jefferies Announces Fourth Quarter 2025 Financial Results

Jan 4, 2026, 4:00 PM EST - 4 months ago

An On-Time Jobs Report. Plus, Albertsons, Constellation, Jefferies, and More Stocks to Watch this Week.

ACI AIR STZ

Dec 31, 2025, 8:46 AM EST - 4 months ago

JEF SHAREHOLDER UPDATE: Jefferies Financial Group Inc. Hit with Securities Investigation after 8% Stock Drop – Contact BFA Law if You Lost Money

Dec 29, 2025, 9:07 AM EST - 4 months ago

JEF INVESTIGATION: Did Jefferies Financial Group Inc. Mislead Investors? Contact BFA Law about its Ongoing Securities Fraud Investigation if You Suffered Losses

Dec 26, 2025, 11:24 AM EST - 4 months ago

Oracle's success will be directly tied to OpenAI's financial strength, says Jefferies' Brent Thill

ORCL

Dec 26, 2025, 10:19 AM EST - 4 months ago

Nike is going to get its act together, says Jefferies' Randy Konik

NKE

Dec 26, 2025, 8:36 AM EST - 4 months ago

Jefferies Financial Group Inc. (JEF) Investors are Notified that Company is being Investigated for Securities Fraud after 8% Stock Drop and are Urged to Contact BFA Law

Dec 22, 2025, 7:18 AM EST - 5 months ago

JEFFERIES INVESTIGATION: Jefferies Financial Group Inc. Hit with Securities Investigation after 8% Stock Drop, Contact BFA Law if You Suffered Losses

Dec 19, 2025, 7:08 AM EST - 5 months ago

JEF LEGAL NOTICE: Lose Money on Jefferies Financial Group Inc.? You may have been Affected by Fraud and are Urged to Contact BFA Law about its Ongoing Investigation

Dec 17, 2025, 4:15 PM EST - 5 months ago

Jefferies to Release its Fourth-Quarter and Annual 2025 Financial Results on January 7, 2026

Dec 17, 2025, 9:07 AM EST - 5 months ago

JEF STOCK NOTICE: Jefferies Financial Group Inc. Faces Securities Fraud Investigation after 8% Stock Drop – Investors with Losses Urged to Contact BFA Law

Dec 12, 2025, 8:36 AM EST - 5 months ago

JEFFERIES NOTICE: Jefferies Financial Group Inc. (JEF) Investors are Notified of Securities Fraud Investigation and to Contact BFA Law if You Suffered Losses

Dec 12, 2025, 8:20 AM EST - 5 months ago

Expect the FOMC to turn dovish next year, says Jefferies' David Zervos

Dec 11, 2025, 7:07 AM EST - 5 months ago

JEF INVESTOR NOTICE: Jefferies Financial Group Inc. Stock Dropped 8% Leading to Securities Fraud Investigation; Contact BFA Law if You Lost Money

Dec 8, 2025, 8:08 AM EST - 5 months ago

JEF INVESTIGATION: Jefferies Financial Group Inc. Securities Fraud Investigation is Pending, Investors Notified to Contact BFA Law

Dec 8, 2025, 6:45 AM EST - 5 months ago

Jefferies to Acquire 50% Interest in Hildene Holding Company, Expanding Strategic Relationship that Began in 2022

Dec 7, 2025, 7:18 AM EST - 5 months ago

JEF INVESTOR LOSSES: Lose Money on Jefferies Financial Group Inc.? Contact BFA Law about its Securities Fraud Investigation

Dec 5, 2025, 8:18 AM EST - 5 months ago

Jefferies Financial Group Inc. (JEF) Investors that Lost Money are Encouraged to Act – Contact BFA Law about its Pending Securities Fraud Investigation

CapitalMonk May. 12 at 5:46 PM

0 · Reply

RunnerSignals May. 11 at 8:22 PM

0 · Reply

dawnfl May. 6 at 10:47 PM

$JEF

0 · Reply

actio May. 2 at 12:01 AM

$JEF Not impossible that tomorrow we will hear additional shares have been bought.

0 · Reply

Ro_Patel Apr. 30 at 1:57 AM

0 · Reply

OnlyFibs Apr. 28 at 1:41 AM

0 · Reply

Ro_Patel Apr. 27 at 3:16 PM

0 · Reply

RunnerSignals Apr. 24 at 8:46 PM

big upside on paper doesnt mean it trades $ROKU $SSRM $JEF $CLX $AR follow price not targets

2 · Reply

unassuming Apr. 24 at 7:34 PM

$HIMS soon we will get $GS and $JEF PTs they will drive us into new ATH with ER soon

0 · Reply

ChristinaC Apr. 24 at 5:30 PM

$JEF is that it, the catalyst for todays reversal? The fundamentals arent at all impressive. Inconsistent and unimpressive earnings results in past several quarters

0 · Reply

unassuming Apr. 17 at 7:57 PM

$JEF no more war = more M&A + IPO UPSIDE THAN EVER BEFORE $60 EOM

0 · Reply

topstockalerts Apr. 17 at 12:42 AM

Kailera Therapeutics has priced its IPO at $16.00 per share for 39,062,500 common shares, aiming to raise $625.0 million in gross proceeds before underwriting discounts and offering expenses. The clinical-stage biotechnology company, focused on obesity treatments, expects its shares to begin trading on the Nasdaq Global Select Market on April 17, 2026, with the offering scheduled to close on April 20, 2026, subject to customary closing conditions. The underwriters have a 30-day option to purchase up to 5,859,375 additional shares at the IPO price, less underwriting discounts and commissions. All shares in the offering are being sold by the company. J.P. Morgan, Jefferies, Leerink Partners, TD Cowen, and Evercore ISI are serving as joint book-running managers, with William Blair acting as lead manager. The SEC declared effective the registration statement on Form S-1 (File No. 333-294690) on April 16, 2026. The company is headquartered in Waltham, Massachusetts. $JPM $EVR $JEF

0 · Reply

Pinnacle_capital1 Apr. 16 at 7:45 PM

$JEF Im looking for a long term short entry. This company is in trouble. (No position)

0 · Reply

Ro_Patel Apr. 16 at 2:21 PM

$MAIR starts trading today - HVAC company Offered 82.7M Class A shares at $27 a share, to raise about $2.2B - w/ 490M shares outstanding - values Madison Air at $13.3B Madison has granted underwriters a 30-day window to buy an additional 12.4M Class A shares at the IPO price. Madison Air has agreed to sell $100M of its Class B shares in a private placement to an entity controlled by the company’s billionaire founder, Larry Gies Operates in a $40B North American market w/ approximately an 8% share Data centers make up just 13% of Madison Air’s revs Backlog of $2.02B Lead Bookers: $GS $BCS $WFC & $JEF

0 · Reply

Estimize Apr. 16 at 11:42 AM

Wall St is expecting 0.71 EPS for $JEF Q2 [Reporting 07/01 AMC] http://www.estimize.com/intro/jef?chart=historical&metric_name=eps&utm_cont

0 · Reply

PenkeInvesting Apr. 12 at 7:51 PM

Fundamental analysis of $JEF (Jefferies Financial Group Inc.) based on financial data and reported results. #JEF

0 · Reply

OnlyFibs Apr. 12 at 12:44 AM

$JEF we crusin now literally caught this at the low, goated entries #hovdid $JEF 1W — Investment bank that went $78.50 → $22.70 (71% drawdown) on recession/tariff panic. Now bouncing to $45.76 — near-double off the low in weeks. Here's what the chart says: ✅ Blue long-term MA at $41–$43 held as the bounce support ✅ RSI hit historic sub-20 at the low ✅ Record weekly volume at the bottom = institutional accumulation ✅ VPVR air pocket above $50 → $54 But white + red MAs at $54–$58 are declining overhead. That's the real target and the real test. 🔴 Res: $50 / $54 white MA / $58 red MA 🟢 Sup: $44–$46 VPVR / $41 blue MA / $38.66 Blue arrow on the chart is right. Target: $54–$58 first. #JEF #Financials #hovdid

0 · Reply

RunnerSignals Apr. 6 at 9:25 PM

$NFLX $JEF $RKT $GAP $ARM Top Stock Upgrades Today in the Buzz 2/2 https://stocksrunner.com/news/2026-04-06-top-stock-upgrades-today-in-the-buzz

0 · Reply

Estimize Apr. 2 at 8:00 PM

Wall St is expecting 0.98 EPS for $JEF Q2 [Reporting 07/01 AMC] http://www.estimize.com/intro/jef?chart=historical&metric_name=eps&utm_cont

0 · Reply

chriswong Apr. 1 at 10:30 PM

$JEF I like the stock.

1 · Reply

OfficialStocktwitsUser Mar. 31 at 3:06 PM

$JEF RSI: 59.56, MACD: -2.4152 Vol: 2.21, MA20: 39.23, MA50: 49.19 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Ro_Patel Mar. 31 at 2:32 PM

$LLY to acquire UK-based $CNTA in a deal worth up to $7.8B - to strengthen its neuroscience pipeline & expand into sleep medicine. Lilly will purchase all Centessa shares, including ADRs, for $38/share + up to an additional $9/share in contingent payments based on FDA approval milestones for Centessa's lead investigational candidate for certain neurological disorders The cash consideration, which represents a premium of about +41% to the 30-day VWAP of Centessa's ADS as of Monday, reflects an equity value of roughly $6.3B w/ the contingent payments represent an additional value of $1.5B Centessa is currently developing a pipeline of orexin receptor 2 agonists to treat excessive daytime sleepiness & disorders of impaired wakefulness. The company's lead investigational candidate, cleminorexton, has been evaluated in a phase 2a clinical trial for narcolepsy types 1 & 2 and idiopathic hypersomnia. Fin advisor for LLY was $MS & for Centessa $JEF

0 · Reply

Market Cap	10.72B
Revenue (ttm)	7.34B
Net Income (ttm)	710.48M
EPS (ttm)	N/A
PE Ratio	15.91
Forward PE	14.00
Profit Margin	9.67%
Debt to Equity Ratio	1.87

Volume	2,250,957
Avg Vol	2,918,646
Day's Range	N/A - N/A
Shares Out	204.43M
Stochastic %K	89%
Beta	1.53
Analysts	Sell
Price Target	$54.60